ChandrakalaRajaMD

PubMed

• Inhibition of micrometastatic prostate cancer cell spread in animal models by 213Bilabeled multiple targeted alpha radioimmunoconjugates.
  Li, Y., Song, E., Abbas Rizvi, S. M., Power, C. A., Beretov, J., Raja, C., Cozzi, P. J., Morgenstern, A., Apostolidis, C., Allen, B. J., Russell, P. J.> ;Clin Cancer Res. 2009 Feb 01
• Preparation and testing of bevacizumab radioimmunoconjugates with Bismuth-213 and Bismuth-205/Bismuth-206.
  Abbas Rizvi, S. M., Song, E. Y., Raja, C., Beretov, J., Morgenstern, A., Apostolidis, C., Russell, P. J., Kearsley, J. H., Abbas, K., Allen, B. J.> ;Cancer Biol Ther. 2008 Oct
• Bismuth-213 radioimmunotherapy with C595 anti-MUC1 monoclonal antibody in an ovarian cancer ascites model.
  Song, E. Y., Qu, C. F., Rizvi, S. M., Raja, C., Beretov, J., Morgenstern, A., Apostolidis, C., Bruchertseifer, F., Perkins, A., Allen, B. J.> ;Cancer Biol Ther. 2008 Jan
• The cytokinesis-block micronucleus assay as a biological dosimeter for targeted alpha therapy.
  Song, E. Y., Rizvi, S. M., Qu, C. F., Raja, C., Yuen, J., Li, Y., Morgenstern, A., Apostolidis, C., Allen, B. J.> ;Phys Med Biol. 2008 Jan 21
• Tumour anti-vascular alpha therapy: a mechanism for the regression of solid tumours in metastatic cancer.
  Allen, B. J., Raja, C., Rizvi, S., Song, E. Y., Graham, P.> ;Phys Med Biol. 2007 Jul 7
• Pharmacokinetics and toxicity of (213)Bi-labeled PAI2 in preclinical targeted alpha therapy for cancer.
  Song, E. Y., Abbas Rizvi, S. M., Qu, C. F., Raja, C., Brechbiel, M. W., Morgenstern, A., Apostolidis, C., Allen, B. J.> ;Cancer Biol Ther. 2007 Jun
• Interim analysis of toxicity and response in phase 1 trial of systemic targeted alpha therapy for metastatic melanoma.
  Raja, C., Graham, P., Abbas Rizvi, S. M., Song, E., Goldsmith, H., Thompson, J., Bosserhoff, A., Morgenstern, A., Apostolidis, C., Kearsley, J., Reisfeld, R., Allen, B...> ;Cancer Biol Ther. 2007 Jun
• Preclinical studies of bismuth-213 labeled plasminogen activator inhibitor type 2 (PAI2) in a prostate cancer nude mouse xenograft model.
  Abbas Rizvi, S. M., Li, Y., Song, E. Y., Qu, C. F., Raja, C., Morgenstern, A., Apostolidis, C., Allen, B. J.> ;Cancer Biol Ther. 2006 Apr
• Pre-clinical study of 213Bi labeled PAI2 for the control of micrometastatic pancreatic cancer.
  Qu, C. F., Song, E. Y., Li, Y., Rizvi, S. M., Raja, C., Smith, R., Morgenstern, A., Apostolidis, C., Allen, B. J.> ;Clin Exp Metastasis. 2005
• Intralesional targeted alpha therapy for metastatic melanoma.
  Allen, B. J., Raja, C., Rizvi, S., Li, Y., Tsui, W., Graham, P., Thompson, J. F., Reisfeld, R. A., Kearsley, J.> ;Cancer Biol Ther. 2005 Dec
• In vivo studies of pharmacokinetics and efficacy of Bismuth-213 labeled antimelanoma monoclonal antibody 9.2.27.
  Rizvi, S. M., Qu, C. F., Song, Y. J., Raja, C., Allen, B. J.> ;Cancer Biol Ther. 2005 Jul
• Cytotoxicity of PAI2, C595 and Herceptin vectors labeled with the alpha-emitting radioisotope Bismuth-213 for ovarian cancer cell monolayers and clusters.
  Song, Y. J., Qu, C. F., Rizvi, S. M., Li, Y., Robertson, G., Raja, C., Morgenstern, A., Apostolidis, C., Perkins, A. C., Allen, B. J.> ;Cancer Lett. 2006 Mar 28
• Targeted alpha therapy for cancer.
  Allen, B. J., Raja, C., Rizvi, S., Li, Y., Tsui, W., Zhang, D., Song, E., Qu, C. F., Kearsley, J., Graham, P., Thompson, J.> ;Phys Med Biol. 2004 Aug 21
• Hip girth as a predictor of abdominal adiposity in postmenopausal women.
  Raja, C., Hansen, R., Baber, R., Allen, B.> ;Nutrition. 2004 Sep
• Cytotoxicity of human prostate cancer cell lines in vitro and induction of apoptosis using 213Bi-Herceptin alpha-conjugate.
  Li, Y., Cozzi, P. J., Qu, C. F., Zhang, D. Y., Abbas Rizvi, S. M., Raja, C., Allen, B. J.> ;Cancer Lett. 2004 Mar 18
• Join now to see all